Showing results (211-220 of 533) with videos related to
Sort By:
Pageof 54
The Journal of Investigative Dermatology|June 9, 2000
Neurotrophin-4 production by human epidermal keratinocytes: increased expression in atopic dermatitisM Grewe, K Vogelsang, T Ruzicka, et al.Praxis|March 21, 2001
[Adjuvant therapy of malignant melanoma]W Franke, N J Neumann, T Ruzicka, et al.Melanoma Research|February 24, 2001
Plantar malignant melanoma -- a challenge for early recognitionW Franke, N J Neumann, T Ruzicka, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 3, 2013
Ex vivo high-definition optical coherence tomography of basal cell carcinoma compared to frozen-section histology in micrographic surgery: a pilot studyT Maier, D Kulichová, T Ruzicka, et al.Acta Dermato-Venereologica|January 1, 1988
Polymorphous light eruption: eliciting and inhibiting wavelengthsB Przybilla, A Galosi, M Heppeler, et al.The British Journal of Dermatology|August 14, 2009
Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinraM Brenner, T Ruzicka, G Plewig, et al.Skin Pharmacology and Applied Skin Physiology|May 27, 1999
Photodynamic diagnosis and therapy in dermatologyC Fritsch, K Lang, W Neuse, et al.Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1993
The lipoxygenase inhibitor 2-phenylmethyl-1-naphthol (DuP 654) is a 12(S)-hydroxyeicosatetraenoic acid receptor antagonist in the human epidermal cell line SCL-IIP Arenberger, A Raap, B Armah, et al.Archives of Dermatological Research|August 1, 1996
Influence of topical photodynamic therapy with 5-aminolevulinic acid on porphyrin metabolismC Fritsch, B Verwohlt, K Bolsen, et al.Clinical and Experimental Dermatology|March 19, 2014
Superimposed lateralized exanthem of childhood: report of a case related to adenovirus infectionA Niedermeier, W Pfützner, T Ruzicka, et al.Pageof 54